This is his strategy which seems to work for him. He is my

New Post Public Reply Private Reply Replies (1) Message Board
StevenRisk thehumanchessmachine #699
116
This is his strategy which seems to work for him. He is my "Dr. Phil" and is always right unless he is not. The only way we would have hit the .80's is if something went terribly wrong. Like him or not he is in for the duration. With that said I do agree with him on the dilution. We (EVIO) needs to get a handle on this. We can not be giving out shares at the 2 year low equivalency of .006(pre-split). We barely had but 1 lab and now were looking to have 18 by year end.New investors and partners need to pay up.

EVIO Inc (EVIO) Stock Research Links

EVIO Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Nippon Steel's High-Stakes Dance to Secure U.S. Steel Deal

Updated Category News Views 130

Nippon Steel’s Drive to Acquire U.S. Steel Reaches a Critical Stage Nippon Steel Corp.’s vice chairman, Takahiro Mori, is heading to the United States to press forward on the company’s proposed $15 billion purchase of United States Steel Corp. His trip centers on meetings with key U.S. officials to work through concerns about foreign ownership and what it might mean...

Continue Reading
Innovative Partnership Between Universal Electronics and Somfy

Updated Category News Views 131

Universal Electronics Partners with Somfy for New Smart Solutions Universal Electronics Inc. (NASDAQ: UEIC), a leader in wireless control technology, has teamed up with Somfy, a pioneer in window and door automation. Their collaboration aims to develop a variety of innovative wireless remote control and sensor products specifically designed for smart motorized shade...

Continue Reading
New Class Action for Investors in Unicycive Therapeutics: What to Know

Updated Category News Views 161

Overview of Unicycive Therapeutics Unicycive Therapeutics, Inc. (NASDAQ: UNCY) is driving advancements in biotechnology, focusing on developing treatments that address critical medical needs. The company is particularly dedicated to addressing conditions related to kidney disease, an area where they aspire to make a significant impact. Details of the Class Action Lawsuit...

Continue Reading
Telit Cinterion Secures U.S. Manufacturing with PA Facility

Updated Category News Views 11

Telit Cinterion Takes a Bold Step in U.S. Manufacturing Here's a move you don't see every day: Telit Cinterion, one of the leading players in the IoT scene, is planting its flag firmly in the good ol' U.S. of A. They're ramping up to start churning out 4G and 5G IoT modules right on American soil by October 2026. This isn't just a small-scale ambition, folks. We're...

Continue Reading
Bayport Management Ltd Financial Overview for December 2023

Updated Category News Views 295

Overview of Bayport Management Ltd's Financial Report Bayport Management Ltd has recently published its audited abridged financial report for December 2023. This report offers valuable insights into the company's performance and overall financial health, providing a clear overview of its operations during this period. Financial Highlights The financial report for December...

Continue Reading